169 related articles for article (PubMed ID: 9144103)
1. The effects of clozapine on cognitive functioning in treatment-resistant schizophrenic patients.
Fujii DE; Ahmed I; Jokumsen M; Compton JM
J Neuropsychiatry Clin Neurosci; 1997; 9(2):240-5. PubMed ID: 9144103
[TBL] [Abstract][Full Text] [Related]
2. Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: a pilot study.
Yi Z; Fan X; Wang J; Liu D; Freudenreich O; Goff D; Henderson DC
Psychiatry Res; 2012 Dec; 200(2-3):79-82. PubMed ID: 22727707
[TBL] [Abstract][Full Text] [Related]
3. The effects of clozapine on cognitive functioning in schizophrenia.
McGurk SR
J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
[TBL] [Abstract][Full Text] [Related]
4. Effects of clozapine on cognitive function in schizophrenia.
Lee MA; Thompson PA; Meltzer HY
J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
[TBL] [Abstract][Full Text] [Related]
5. Add-on mirtazapine enhances effects on cognition in schizophrenic patients under stabilized treatment with clozapine.
Delle Chiaie R; Salviati M; Fiorentini S; Biondi M
Exp Clin Psychopharmacol; 2007 Dec; 15(6):563-8. PubMed ID: 18179309
[TBL] [Abstract][Full Text] [Related]
6. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
7. Combined clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia: clinical and cognitive outcomes.
Biedermann F; Pfaffenberger N; Baumgartner S; Kemmler G; Fleischhacker WW; Hofer A
J ECT; 2011 Dec; 27(4):e61-2. PubMed ID: 22124226
[TBL] [Abstract][Full Text] [Related]
8. Determinants of work outcome in neuroleptic-resistant schizophrenia and schizoaffective disorder: cognitive impairment and clozapine treatment.
Kaneda Y; Jayathilak K; Meltzer H
Psychiatry Res; 2010 Jun; 178(1):57-62. PubMed ID: 20452677
[TBL] [Abstract][Full Text] [Related]
9. Cognitive differences in schizophrenia on long-term treatments with clozapine, risperidone and typical antipsychotics.
Han M; Zhang XY; Chen DC; Tan YL; Song CS; Yu YH; Huang XF
Int Clin Psychopharmacol; 2015 Mar; 30(2):89-95. PubMed ID: 25568968
[TBL] [Abstract][Full Text] [Related]
10. The relationship of neuropsychological test performance with the PANSS in antipsychotic naïve, first-episode psychosis patients.
Good KP; Rabinowitz J; Whitehorn D; Harvey PD; DeSmedt G; Kopala LC
Schizophr Res; 2004 May; 68(1):11-9. PubMed ID: 15037335
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind comparison of ziprasidone vs. clozapine for cognition in patients with schizophrenia selected for resistance or intolerance to previous treatment.
Harvey PD; Sacchetti E; Galluzzo A; Romeo F; Gorini B; Bilder RM; Loebel AD
Schizophr Res; 2008 Oct; 105(1-3):138-43. PubMed ID: 18077136
[TBL] [Abstract][Full Text] [Related]
12. Profiling cognitive impairment in treatment-resistant schizophrenia patients.
Frydecka D; Beszłej JA; Gościmski P; Kiejna A; Misiak B
Psychiatry Res; 2016 Jan; 235():133-8. PubMed ID: 26706131
[TBL] [Abstract][Full Text] [Related]
13. Effects of sertindole on cognition in clozapine-treated schizophrenia patients.
Nielsen RE; Levander S; Thode D; Nielsen J
Acta Psychiatr Scand; 2012 Jul; 126(1):31-9. PubMed ID: 22356584
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia.
Manschreck TC; Redmond DA; Candela SF; Maher BA
J Neuropsychiatry Clin Neurosci; 1999; 11(4):481-9. PubMed ID: 10570762
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
17. Comparing cognitive functions in medication adherent and non-adherent patients with schizophrenia.
El-Missiry A; Elbatrawy A; El Missiry M; Moneim DA; Ali R; Essawy H
J Psychiatr Res; 2015 Nov; 70():106-12. PubMed ID: 26424429
[TBL] [Abstract][Full Text] [Related]
18. Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
Muscatello MR; Bruno A; Pandolfo G; Micò U; Bellinghieri PM; Scimeca G; Cacciola M; Campolo D; Settineri S; Zoccali R
J Psychopharmacol; 2011 May; 25(5):667-74. PubMed ID: 20615930
[TBL] [Abstract][Full Text] [Related]
19. The effect of clozapine on the speed and accuracy of information processing in schizophrenia.
Galletly CA; Clark CR; McFarlane AC; Weber DL
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1329-38. PubMed ID: 11125857
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia.
Meltzer HY; Bobo WV; Lee MA; Cola P; Jayathilake K
Psychiatry Res; 2010 May; 177(3):286-93. PubMed ID: 20378185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
